Original Articles| Volume 12, ISSUE 1, P29-36, January 2003

Download started.


Strategic involvement of cholinergic pathways and executive dysfunction: Does location of white matter signal hyperintensities matter?


      Cholinergic therapies have proven efficacious in the treatment of Alzheimer's disease, and recently in vascular and mixed dementia. We set out to evaluate the impact of putative cerebrovascular lesions involving cholinergic pathways in patients with cognitive impairment. White matter signal hyperintensities on magnetic resonance imaging involving cholinergic projections were classified according to a three-point rating scale for 171 individuals with cognitive impairment and 34 normal elderly controls. Medial temporal lobe width was measured, and a neuropsychological test battery was administered. Moderate or severe involvement of cholinergic pathways by white matter signal hyperintensities were identified in 60% of subjects with probable vascular dementia, 30% of subjects with possible/probable Alzheimer's disease, and 40% of subjects with cognitive impairment but no dementia. All control subjects were found to have minimal cholinergic pathway involvement. Medial temporal lobe width and signal hyperintensities on magnetic resonance imaging affecting cholinergic pathways were inversely related. Individuals with moderate and severe involvement of cholinergic pathways by white matter signal hyperintensities had greater impairment of executive function and visuospatial attention, despite equivalent degrees of global impairment and memory dysfunction when compared to those with minimal cholinergic pathway involvement. This is the first study to suggest that cerebrovascular disease may directly affect cholinergic projections and may exacerbate pre-existing cholinergic deficits of a degenerative nature, especially in probable Alzheimer's disease. Cerebrovascular compromise of cholinergic white matter projections may therefore be relevant in understanding the effects of cholinergic therapies. Copyright © 2003 by National Stroke Association


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Hulette C
        • Nochlin D
        • McKeel D
        • et al.
        Clinical-neuropathologic findings in multi-infarct dementia: a report of six autopsied cases.
        Neurology. 1997; 48: 668-672
        • Snowdon DA
        • Greiner LH
        • Mortimer JA
        • et al.
        Brain infarction and the clinical expression of Alzheimer disease. The Nun Study.
        JAMA. 1997; 277: 813-817
        • Vermeer SE
        • Koudstaal PJ
        • Oudkerk M
        • et al.
        Prevalence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study.
        Stroke. 2002; 33: 21-25
        • Perry EK
        The cholinergic system in old age and Alzheimer's disease.
        Age Ageing. 1980; 9: 1-8
        • Doody RS
        • Stevens JC
        • Beck C
        • et al.
        Practice parameter: Management of dementia (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology.
        Neurology. 2001; 56: 1154-1166
        • Erkinjuntii T
        • Kurz A
        • Gauthier S
        • et al.
        Efficacy of galantamine in probable vascular dementia and Alzheimer's disease combined with cerebrovascular disease: a randomized trial.
        Lancet. 2002; 359: 1283-1290
        • Perdomo CA
        • Pratt RD
        A comparison of the effects of donepezil in patients with probable and possible vascular dementia: A combined analysis of two 24-week, randomized, double-blind, placebo-controlled trials (abstract).
        Neurology. 2002; 58: A382
        • Mesulam MM
        • Geula C
        Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase.
        J Comp Neurol. 1988; 275: 216-240
        • Selden NR
        • Gitelman DR
        • Salamon-Murayama N
        • et al.
        Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain.
        Brain. 1998; 121: 2249-2257
        • Lawrence AD
        • Sahakian BJ
        Alzheimer disease, attention, and the cholinergic system.
        Alzheimer Dis Assoc Disord. 1995; 9: 43-49
        • Johnson DA
        • Zambon NJ
        • Gibbs RB
        Selective lesion of cholinergic neurons in the medial septum by 192 IgG-saporin impairs learning in a delayed matching to position T-maze paradigm.
        Brain Res. 2002; 943: 132-141
        • Muir JL
        • Page KJ
        • Sirinathsinghji DJ
        • et al.
        Excitotoxic lesions of basal forebrain cholinergic neurons: effects on learning, memory and attention.
        Behav Brain Res. 1993; 57: 123-131
        • Voytko ML
        • Olton DS
        • Richardson RT
        • et al.
        Basal forebrain lesions in monkeys disrupt attention but not learning and memory.
        J Neurosci. 1994; 14: 167-186
        • Pang K
        • Williams MJ
        • Egeth H
        • et al.
        Nucleus basalis magnocellularis and attention: effects of muscimol infusions.
        Behav Neurosci. 1993; 107: 1031-1038
        • American Psychiatric Association
        Diagnostic and statistical manual of mental disorders.
        in: American Psychiatric Association, Washington DC1994: 4
        • McKhann G
        • Drachman DA
        • Folstein MF
        • et al.
        Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Workgroup under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.
        Neurology. 1984; 34: 939-944
        • Roman GC
        • Tatemichi TK
        • Erkinjuntti T
        • et al.
        Vascular dementia: Diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop.
        Neurology. 1993; 43: 250-260
        • Graham JE
        • Rockwood K
        • Beattie BL
        • et al.
        Prevalence and severity of cognitive impairment with and without dementia in an elderly population.
        Lancet. 1997; 349: 1793-1796
        • Mattis S
        Mental Status Examination for Organic Mental Syndrome in the Elderly Patient.
        in: Geriatric Psychiatry. Grune and Stratton, New York1976
        • Delis DC
        • Kramer JH
        • Kaplan E
        • et al.
        California Verbal Learning Test: Adult Version.
        The Psychological Corporation, San Antonio, Texas1987
        • Wechsler D
        Wechsler Memory Scale—Revised.
        The Psychological Corporation, New York1987
        • Lezack MD
        Neuropsychological assessment.
        Oxford University Press, New York1983
        • Heaton RK
        Wisconsin Card Sorting Test manual.
        Psychological Assessment Resources, Odessa, Florida1981
        • Benton AL
        • Hamsher K
        • Varney NR
        • et al.
        Contributions to Neuropsychological Assessment.
        Oxford University Press, New York1983
        • Kaplan EF
        • Goodglass H
        • Weintraub S
        The Boston Naming Test.
        Lea and Febiger, Boston1978
        • Gao FQ
        • Black SE
        • Leibovitch FS
        • et al.
        A reliable MR measurement of medial temporal lobe width from the Sunnybrook Dementia Study.
        Neurobiol Aging. 2003; 24: 49-56
        • Fleiss JL
        Reliability of measurement. The Design and Analysis of Clinical Experiments.
        in: John Wiley and Sons, New York1986: 1-32
        • Wenk GL
        The nucleus basalis magnocellularis cholinergic system: one hundred years of progress.
        Neurobiol Learn Mem. 1997; 67: 85-95
        • Hirono N
        • Kitagaki H
        • Kazui H
        • et al.
        Impact of white matter changes on clinical manifestation of Alzheimer's disease: A quantitative study.
        Stroke. 2000; 31: 2182-2188
        • Lee J-H
        • Olichney JM
        • Hansen LA
        • et al.
        Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease.
        Arch Neurol. 2000; 57: 1474-1479
        • Esiri MM
        • Nagy Z
        • Smith MZ
        • et al.
        Cerebrovascular disease and threshold for dementia in the early stages of Alzheimer's disease.
        Lancet. 1999; 354: 919-920
        • Tsiskaridze A
        • Shakarishvili R
        • Janelidze M
        • et al.
        Cognitive correlates of leukoaraiosis in the early stages of Alzheimer's disease.
        Funct Neurol. 1998; 13: 17-25
        • DeCarli C
        • Murphy DG
        • Tranh M
        • et al.
        The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults.
        Neurology. 1995; 45: 2077-2084
        • Amar K
        • Bucks RS
        • Lewis T
        • et al.
        The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type.
        Age Ageing. 1996; 25: 443-448
        • Gold G
        • Giannakopoulos P
        • Montes-Paixao JC
        • et al.
        Sensitivity and specificity of newly proposed clinical criteria for possible vascular dementia.
        Neurology. 1997; 49: 690-694
        • Roses AD
        • Saunders AM
        Clinical overdiagnosis of vascular dementia versus necropsy confirmed series.
        J Neurol Neurosurg Psychiatry. 1997; 62: 677-678
        • van Gijn J
        Leukoaraiosis and vascular dementia.
        Neurology. 1998; 51: S3-S8
        • Pantoni L
        • Leys D
        • Fazekas F
        • et al.
        Role of white matter lesions in cognitive impairment of vascular origin.
        Alzheimer Dis Assoc Disord. 1999; 13: S49-S54
        • Erkinjuntti T
        • Inzitari D
        • Pantoni L
        • et al.
        Research criteria for subcortical vascular dementia in clinical trials.
        J Neural Transm Suppl. 2000; 59: 23-30
        • Lee SC
        • Park SJ
        • Ki HK
        • et al.
        Prevalence and risk factors of silent cerebral infarction in apparently normal adults.
        Hypertension. 2000; 36: 73-77